These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22227913)

  • 1. Interpretation of health and vision utilities in low vision patients.
    Malkin AG; Goldstein JE; Massof RW
    Optom Vis Sci; 2012 Mar; 89(3):288-95. PubMed ID: 22227913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examination of assumptions in using time tradeoff and standard gamble utilities in individuals with spinal cord injury.
    Lin MR; Yu WY; Wang SC
    Arch Phys Med Rehabil; 2012 Feb; 93(2):245-52. PubMed ID: 22289233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new explanation for the difference between time trade-off utilities and standard gamble utilities.
    Bleichrodt H
    Health Econ; 2002 Jul; 11(5):447-56. PubMed ID: 12112493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correcting biases in standard gamble and time tradeoff utilities.
    van Osch SM; Wakker PP; van den Hout WB; Stiggelbout AM
    Med Decis Making; 2004; 24(5):511-7. PubMed ID: 15359000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health values of patients with chronic hepatitis C infection.
    Sherman KE; Sherman SN; Chenier T; Tsevat J
    Arch Intern Med; 2004 Nov; 164(21):2377-82. PubMed ID: 15557419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming inherent problems of preference-based techniques for measuring health benefits: an empirical study in the context of kidney transplantation.
    Kontodimopoulos N; Niakas D
    BMC Health Serv Res; 2006 Jan; 6():3. PubMed ID: 16412242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health values of adolescents with cystic fibrosis.
    Yi MS; Britto MT; Wilmott RW; Kotagal UR; Eckman MH; Nielson DW; Kociela VL; Tsevat J
    J Pediatr; 2003 Feb; 142(2):133-40. PubMed ID: 12584533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility values in the visually impaired: comparing time-trade off and VisQoL.
    Gothwal VK; Bagga DK
    Optom Vis Sci; 2013 Aug; 90(8):843-54. PubMed ID: 23628757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility assessment method order influences measurement of parents' risk attitude.
    Finnell SM; Carroll AE; Downs SM
    Value Health; 2012; 15(6):926-32. PubMed ID: 22999143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health state utilities in gastroesophageal reflux disease patients with heartburn: a study in Germany and Sweden.
    Kartman B; Gatz G; Johannesson M
    Med Decis Making; 2004; 24(1):40-52. PubMed ID: 15005953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility values in patients with acquired anophthalmus.
    Hirneiss C; Neubauer AS; Herold TR; Kampik A; Hintschich C
    Orbit; 2009; 28(6):332-6. PubMed ID: 19929654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thigh laxity after massive weight loss: a utilities outcomes assessment.
    Izadpanah A; Sinno H; Vorstenbosch J; Lee BT; Lin SJ
    Ann Plast Surg; 2013 Sep; 71(3):304-7. PubMed ID: 23788144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility weights for the vision-related Assessment of Quality of Life (AQoL)-7D instrument.
    Richardson J; Iezzi A; Peacock S; Sinha K; Khan M; Misajon R; Keeffe J
    Ophthalmic Epidemiol; 2012 Jun; 19(3):172-82. PubMed ID: 22568431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rating scale, standard gamble, and time trade-off for people with traumatic spinal cord injuries.
    Lin MR; Hwang HF; Chung KP; Huang C; Chen CY
    Phys Ther; 2006 Mar; 86(3):337-44. PubMed ID: 16506870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices.
    Moore AD; Clarke AE; Danoff DS; Joseph L; Bélisle P; Neville C; Fortin PR
    J Rheumatol; 1999 Jun; 26(6):1285-90. PubMed ID: 10381044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of general health status on validity of visual impairment measurement.
    Ahmadian L; Massof R
    Ophthalmic Epidemiol; 2008; 15(5):345-55. PubMed ID: 18850472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vision and quality-of-life.
    Brown GC
    Trans Am Ophthalmol Soc; 1999; 97():473-511. PubMed ID: 10703139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The standard gamble showed better construct validity than the time trade-off.
    Puhan MA; Schünemann HJ; Wong E; Griffith L; Guyatt GH
    J Clin Epidemiol; 2007 Oct; 60(10):1029-33. PubMed ID: 17884597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life in patients with uveitis.
    Shamdas M; Bassilious K; Murray PI
    Br J Ophthalmol; 2019 Sep; 103(9):1284-1288. PubMed ID: 30361275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of EuroQOL-5D, time trade-off, and standard gamble for age-related macular degeneration in the Singapore population.
    Au Eong KG; Chan EW; Luo N; Wong SH; Tan NW; Lim TH; Wagle AM
    Eye (Lond); 2012 Mar; 26(3):379-88. PubMed ID: 22222257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.